Voloridge Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-22,792
Closed -$2.49M – 964
2026
Q1
$2.49M Sell
22,792
-40,117
-64% -$3.82M 0.01% 797
2025
Q4
$5.1M Buy
62,909
+25,901
+70% +$2.23M 0.02% 757
2025
Q3
$3.24M Buy
+37,008
New +$3.3M 0.01% 836
2023
Q4
– Sell
-10,037
Closed -$547K – 1333
2023
Q3
$547K Buy
10,037
+3,027
+43% +$179K ﹤0.01% 1201
2023
Q2
$472K Buy
+7,010
New +$428K ﹤0.01% 1240
2020
Q1
– Sell
-16,351
Closed -$588K – 1261
2019
Q4
$588K Buy
+16,351
New +$564K 0.01% 780

Other funds holding LMAT

Voloridge Investment Management's LMAT Position: Q2 2026 in Review

Voloridge Investment Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 22,792 shares — an estimated $2.49M sold.

Voloridge Investment Management first reported a position in LMAT in Q4 2019 and held it in 6 quarters. The position peaked at $5.1M in Q4 2025. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Voloridge Investment Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 22,792 LeMaitre Vascular shares in Q2 2026, an estimated $2.49M.
  • Voloridge Investment Management first reported a position in LeMaitre Vascular in Q4 2019 and held it in 6 quarters.
  • Voloridge Investment Management's LeMaitre Vascular position peaked at $5.1M in Q4 2025.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.